Proteomic and systems biology analysis of monocytes exposed to securinine, a GABA(A) receptor antagonist and immune adjuvant
- PMID: 23028424
- PMCID: PMC3441550
- DOI: 10.1371/journal.pone.0041278
Proteomic and systems biology analysis of monocytes exposed to securinine, a GABA(A) receptor antagonist and immune adjuvant
Abstract
Securinine, a GABA(A) receptor antagonist, has been reported to enhance monocyte cell killing of Coxiella burnetii without obvious adverse effects in vivo. We employed multiplex 2D gel electrophoresis using Zdyes, a new generation of covalently linked fluorescent differential protein detection dyes to analyze changes in the monocyte proteome in response to Securinine. Securinine antagonism of GABA(A) receptors triggers the activation of p38. We used the differential protein expression results to guide a search of the literature and network analysis software to construct a systems biology model of the effect of Securinine on monocytes. The model suggests that various metabolic modulators (fatty acid binding protein 5, inosine 5'-monophosphate dehydrogenase, and thioredoxin) are at least partially reshaping the metabolic landscape within the monocytes. The actin bundling protein L-plastin, and the Ca(2+) binding protein S100A4 also appear to have important roles in the immune response stimulated by Securinine. Fatty acid binding protein 5 (FABP5) may be involved in effecting lipid raft composition, inflammation, and hormonal regulation of monocytes, and the model suggests that FABP5 may be a central regulator of metabolism in activated monocytes. The model also suggests that the heat shock proteins have a significant impact on the monocyte immune response. The model provides a framework to guide future investigations into the mechanisms of Securinine action and with elaboration may help guide development of new types of immune adjuvants.
Conflict of interest statement
Figures
Similar articles
-
Securinine, a GABAA receptor antagonist, enhances macrophage clearance of phase II C. burnetii: comparison with TLR agonists.J Leukoc Biol. 2007 Nov;82(5):1062-9. doi: 10.1189/jlb.0407255. Epub 2007 Aug 14. J Leukoc Biol. 2007. PMID: 17698917
-
Securinine alkaloids: a new class of GABA receptor antagonist.Brain Res. 1985 Mar 18;330(1):135-40. doi: 10.1016/0006-8993(85)90014-9. Brain Res. 1985. PMID: 2985189
-
Securinine, a myeloid differentiation agent with therapeutic potential for AML.PLoS One. 2011;6(6):e21203. doi: 10.1371/journal.pone.0021203. Epub 2011 Jun 24. PLoS One. 2011. PMID: 21731671 Free PMC article.
-
Securinega suffruticosa.Fitoterapia. 2008 Sep;79(6):419-27. doi: 10.1016/j.fitote.2008.02.011. Epub 2008 Jun 5. Fitoterapia. 2008. PMID: 18534774 Review.
-
The Securinega alkaloids.Alkaloids Chem Biol. 2015;74:1-120. doi: 10.1016/bs.alkal.2014.11.001. Alkaloids Chem Biol. 2015. PMID: 25845059 Review.
Cited by
-
Physiological, biomass elemental composition and proteomic analyses of Escherichia coli ammonium-limited chemostat growth, and comparison with iron- and glucose-limited chemostat growth.Microbiology (Reading). 2015 Aug;161(8):1659-1670. doi: 10.1099/mic.0.000118. Epub 2015 May 26. Microbiology (Reading). 2015. PMID: 26018546 Free PMC article.
-
Proteomic and systems biology analysis of the monocyte response to Coxiella burnetii infection.PLoS One. 2013 Aug 21;8(8):e69558. doi: 10.1371/journal.pone.0069558. eCollection 2013. PLoS One. 2013. PMID: 23990884 Free PMC article.
-
In-Depth Proteomic Characterization of Classical and Non-Classical Monocyte Subsets.Proteomes. 2018 Feb 5;6(1):8. doi: 10.3390/proteomes6010008. Proteomes. 2018. PMID: 29401756 Free PMC article.
-
Molecular Mechanisms of Medicinal Plant Securinega suffruticosa-derived Compound Securinine against Spinal Muscular Atrophy based on Network Pharmacology and Experimental Verification.Curr Pharm Des. 2024;30(15):1178-1193. doi: 10.2174/0113816128288504240321041408. Curr Pharm Des. 2024. PMID: 38561613
-
Anti-Inflammatory and Neuroprotective Role of Natural Product Securinine in Activated Glial Cells: Implications for Parkinson's Disease.Mediators Inflamm. 2017;2017:8302636. doi: 10.1155/2017/8302636. Epub 2017 Apr 4. Mediators Inflamm. 2017. PMID: 28473732 Free PMC article.
References
-
- Lubick K, Radke M, Jutila M (2007) Securinine, a GABAA receptor antagonist, enhances macrophage clearance of phase II C. burnetii: comparison with TLR agonists. The Journal of Leukocyte Biology 82: 1062–1069. - PubMed
-
- Beutler JA, Karbon EW, Brubaker AN, Malik R, Curtis DR, et al. (1985) Securinine alkaloids: a new class of GABA receptor antagonist. Brain Research 330: 135–140. - PubMed
-
- Alam S, Laughton DL, Walding A, Wolstenholme AJ (2006) Human peripheral blood mononuclear cells express GABAA receptor subunits. Molecular Immunology 43: 1432–1442. - PubMed
-
- Reyes-García MG, Hernández-Hernández Fl, Hernádex-Téllez B, García-Tamayo F (2007) GABAA receptor subunits RNA expression in mice peritoneal macrophages modulate their IL-6/IL-12 production. Journal of Neuroimmunology 188: 64–68. - PubMed
-
- Bjurstöm H, Wang J-Y, Ericsson I, Bengtsson M, Liu Y, et al. (2008) GABA, a natural immunomodulator of T lymphocytes. Journal of Neuroimmunology 205: 44–50. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous